Amrad shareholders stock up
Thursday, 22 July, 2004
Some of Amrad's larger shareholders are boosting their holdings in the Melbourne company (ASX:AML), as long-time Japanese investor Chugai divests itself of its 10 per cent stake in the company.
Yesterday the Queensland Investment Corporation -- a major institutional player in Australia's biotechnology sector -- filed documents with the ASX indicating that it had increased its holdings from 5.45 per cent to 10.495 per cent.
And today, the Thorney group, run by multi-millionaire Richard Pratt, said it had raised its stake in the company from 9.14 per cent to 11.88 per cent.
Chugai retains a 2.52 per cent share of the company, making $4.3 million out of the sale of its shares.
The relationship between Amrad and Chugai stretches back 10 years, over which time the Japanese company invested about $20 million into Amrad. But the joint research contract came to a natural end last year when its term expired.
Statins reduce heart attack and stroke risk in older people
It has previously been unclear whether statins were effective in reducing heart attack and stroke...
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
